Meridian Financial »

United Therapeutics Corporation shares owned by Meridian Financial

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Meridian Financial from 13F filings

Historical chart of Meridian Financial investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Meridian Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Meridian Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $280k 780 358.35
2024-06-30 $249k 780 318.55
2024-03-31 $230k 1.0k 229.72
2023-12-31 $220k 1.0k 219.89
2023-09-30 $226k 1.0k 225.87
2023-06-30 $247k 1.1k 220.75
2023-03-31 $251k 1.1k 223.96

More positions owned by Meridian Financial

Schwab Strategic Tr Us Dividend Eq (SCHD)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Div Grwth (DGRO)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Microsoft Corporation (MSFT)
Spdr Ser Tr S&p Divid Etf (SDY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Small Cp Etf (VB)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)

View all positions for Meridian Financial

Top funds holding United Therapeutics Corporation

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Geode Capital Management
LSV Asset Management
Morgan Stanley
AQR Capital Management
Dimensional Fund Advisors
Hanna Zanoni
Pacer Advisors
Alliancebernstein
Arrowstreet Capital, Limited Partnership
Nuveen Asset Management

View all funds holding United Therapeutics Corporation